<DOC>
	<DOCNO>NCT00903253</DOCNO>
	<brief_summary>The objective study evaluate single-dose plasma pharmacokinetics LNK-754 well safety tolerability normal healthy male female elderly volunteer</brief_summary>
	<brief_title>A Double-Blind , Placebo Controlled , Single , Escalating Dose Study Evaluate Preliminary Pharmacokinetics , Safety Tolerability LNK-754 Healthy Elderly Volunteers</brief_title>
	<detailed_description />
	<criteria>Males Females age 60 75 year Good general health determine medical history physical examination Body Mass Index 1832 , inclusive Estimate creatinine clearance CockcroftGault normal age sex ( great equal 60mL/min ) Normal hemoccult test screen baseline Voluntarily consent participate study Willing adhere protocol requirement Subjects clinically significant cardiovascular , pulmonary , renal , hepatic , gastrointestinal , neurological , sleep disorder DSMIV criterion , endocrine , hematological , metabolic disease determine medical history physical examination Subjects diagnose meet Diagnostic Statistical Manual Mental Disorders Fourth Edition , Text Revision ( DSMIV_TR ) criteria significant psychiatric psychoactive substance use disorder within past year Subjects positive urine drug screen compound associate abuse absence medical justification presence QTcB great 450 msec ( male ) , great 470 ( female ) , base average interval triplicate ECGs obtain five minute rest supine position use hte ECG algorithm Clinically significant abnormal screening result laboratory test Pregnant nursing planning pregnancy , plan father child</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>